封面
市場調查報告書
商品編碼
1547994

全球合法大麻市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Legal Marijuana Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

全球合法大麻市場需求預計將從 2023 年的 207.8 億美元達到近 1,499.9 億美元的市場規模,2024-2032 年研究期間複合年成長率為 24.56%。

一些國家已將出於醫療和娛樂目的持有、分配、種植和消費大麻合法化。而且,在大多數國家,這些政策均受《聯合國麻醉藥品單一公約》監管。大麻在市場上有多種形式:花蕾、油和酊劑。這種精神活性藥物的醫學應用會導致慢性疼痛、精神障礙、癌症和其他神經系統疾病。大麻的成人用途包括用作食品成分和精神藥物。

市場動態

隨著醫療和成人用途的合法大麻使用量激增,全球對其的需求預計將大幅增加。此外,對疼痛管理治療的需求不斷成長,加上老年族群慢性疼痛負擔的增加,預計將提高產品需求。然而,COVID-19大流行對消費者的購買能力和無縫貿易施加了一些限制。這是合法大麻市場面臨的主要挑戰。另一方面,大麻在治療多種疾病、癌症、焦慮症、帕金森氏症和阿茲海默症方面的應用範圍預計將預示著產品在全球市場的滲透。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具還對全球合法大麻市場的每個細分市場進行了包容性評估。合法大麻產業的成長和趨勢為本研究提供了整體方法。

市場區隔

合法大麻市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按申請

  • 醫療(慢性疼痛、癌症、憂鬱和焦慮、關節炎、糖尿病、青光眼、偏頭痛、癲癇、多發性硬化症、愛滋病、肌萎縮側索硬化症、阿茲海默症、創傷後壓力症候群( PTSD)、巴金森氏症、妥瑞氏症等)
  • 成人使用

依產品類型

  • 油和酊劑

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲合法大麻市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。合法大麻市場的主要參與者包括頂篷 Growth Corporation、Aurora Cannabis Inc.、Tilray Brands Inc. (Aphria Inc.)、Abcann Medicinals Inc. (Vivo Cannabis Inc.)、The Cronos Group、Maricann Inc.、 Organigram Holdings Inc. .、Lexaria Bioscience、Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.)、Tikun Olam、United Cannabis Corporation。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:合法大麻 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 市場吸引力分析:依應用分類
    • 市場吸引力分析:按產品類型
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球合法大麻市場分析:按應用分類

  • 概述:按應用
  • 歷史和預測數據
  • 分析:按應用
  • 醫療(慢性疼痛、癌症、憂鬱和焦慮、關節炎、糖尿病、青光眼、偏頭痛、癲癇、多發性硬化症、愛滋病、肌萎縮側索硬化症、阿茲海默症、創傷後壓力症候群( PTSD)、帕金森氏症、抽動穢語等)
  • 成人使用

第 6 章:全球合法大麻市場分析:按產品類型

  • 概述:按產品類型
  • 歷史和預測數據
  • 分析:依產品類型
  • 油和酊劑

第 7 章:全球合法大麻市場分析:按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章:合法大麻公司的競爭格局

  • 合法大麻市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Canopy Growth Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Aurora Cannabis Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Tilray Brands Inc. (Aphria Inc.)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Abcann Medicinals Inc. (Vivo Cannabis Inc.)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • The Cronos Group
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Maricann Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Organigram Holdings Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Lexaria Bioscience
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Tikun Olam
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • United Cannabis Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中,財務詳細資訊和最新發展視情況而定,或對私人公司而言可能不包括在內

Product Code: VMR11212091

The global demand for Legal Marijuana Market is presumed to reach the market size of nearly USD 149.99 Billion by 2032 from USD 20.78 Billion in 2023 with a CAGR of 24.56% under the study period 2024-2032.

Several countries have legalized possession, distribution, cultivation, and consumption of marijuana for medical and recreational purposes. And, in most nations, these policies are regulated by the United Nations Single Convention on Narcotic Drugs. Marijuana is available in several forms in the market, buds, oil, and tinctures. The medical application of this psychoactive drug is subjected to chronic pain, mental disorders, cancer, and other neurological diseases. The Adult-use of marijuana can range from being used as a food ingredient to a psychoactive drug.

MARKET DYNAMICS

With the soar in the use of legal marijuana for medical and adult-use, the global demands for the same are anticipated to grow significantly. Moreover, the growing need for pain management treatments along with the rising burden of chronic pain among the geriatric population is anticipated to lift the product demand. However, the COVID-19 pandemic has imposed several restrictions in terms of the buying capability of consumers and seamless trade. This acts as a key challenge for the legal marijuana market. On the other side, the scope of marijuana in treating several ailments, cancer, anxiety, and Parkinson's and Alzheimer's disease is anticipated to bode well for product penetration in the global market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Legal Marijuana. The growth and trends of Legal Marijuana industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Legal Marijuana market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Medical (Chronic Pain, Cancer, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer's, Post-traumatic Stress Disorder (PTSD), Parkinson's, Tourette's, Others)
  • Adult Use

By Product Type

  • Flower
  • Oil & Tinctures

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Legal Marijuana market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Legal Marijuana market include Canopy Growth Corporation, Aurora Cannabis Inc., Tilray Brands Inc. (Aphria Inc.), Abcann Medicinals Inc. (Vivo Cannabis Inc.), The Cronos Group, Maricann Inc., Organigram Holdings Inc., Lexaria Bioscience, Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.), Tikun Olam, United Cannabis Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. LEGAL MARIJUANA - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By Product Type
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL LEGAL MARIJUANA MARKET ANALYSIS BY APPLICATION

  • 5.1. Overview By Application
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Application
  • 5.4. Medical (Chronic Pain, Cancer, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer's, Post-traumatic Stress Disorder (PTSD), Parkinson's, Tourette's, Others) Historic and Forecast Sales By Regions
  • 5.5. Adult Use Historic and Forecast Sales By Regions

6. GLOBAL LEGAL MARIJUANA MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1. Overview By Product Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Product Type
  • 6.4. Flower Historic and Forecast Sales By Regions
  • 6.5. Oil & Tinctures Historic and Forecast Sales By Regions

7. GLOBAL LEGAL MARIJUANA MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE LEGAL MARIJUANA COMPANIES

  • 8.1. Legal Marijuana Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF LEGAL MARIJUANA INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Canopy Growth Corporation
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Aurora Cannabis Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Tilray Brands Inc. (Aphria Inc.)
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Abcann Medicinals Inc. (Vivo Cannabis Inc.)
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. The Cronos Group
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Maricann Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Organigram Holdings Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Lexaria Bioscience
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.)
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Tikun Olam
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. United Cannabis Corporation
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Application (USD MN)
  • Medical (Chronic Pain, Cancer, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer's, Post-traumatic Stress Disorder (PTSD), Parkinson's, Tourette's, Others) Market Sales By Geography (USD MN)
  • Adult Use Market Sales By Geography (USD MN)
  • Analysis By Product Type (USD MN)
  • Flower Market Sales By Geography (USD MN)
  • Oil & Tinctures Market Sales By Geography (USD MN)
  • Global Legal Marijuana Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Legal Marijuana Report
  • Market Research Process
  • Market Research Methodology
  • Global Legal Marijuana Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Application (USD MN)
  • Medical (Chronic Pain, Cancer, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer's, Post-traumatic Stress Disorder (PTSD), Parkinson's, Tourette's, Others) Market Sales By Geography (USD MN)
  • Adult Use Market Sales By Geography (USD MN)
  • Global Market Analysis By Product Type (USD MN)
  • Flower Market Sales By Geography (USD MN)
  • Oil & Tinctures Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.